Top Story

DEFLECT III: Cerebral protection device safe at 30 days after TAVR

DEFLECT III: Cerebral protection device safe at 30 days after TAVR
May 29, 2015

Cerebral protection with an investigational device designed to deflect debris away from the brain during transcatheter aortic valve replacement was safe at 30 days, according to new data presented at EuroPCR 2015.

Patients who underwent protected TAVR also had a higher rate of freedom from ischemic brain lesions, less neurologic deficit, and improved cognitive function at discharge and 30 days compared with patients who underwent TAVR without neuroprotection.

HHS announces new payment initiative for reducing CVD

May 29, 2015
The Centers for Medicare and Medicaid Services has announced they will be accepting applications for a new ACA payment model, designed to reduce the risk of CVD in…
Sanjit Jolly, MD, MSc Meeting News Coverage

TOTAL: Stroke risk linked to manual thrombectomy during PCI evident within 48 hours

May 29, 2015
The increased stroke risk associated with manual thrombectomy during primary PCI detected in the TOTAL trial was evident within the first 48 hours after the procedure…
VIDEO: New cholesterol guidelines, risk calculator key to improving patient care Meeting News CoverageVideo

VIDEO: New cholesterol guidelines, risk calculator key to improving patient care

May 29, 2015
SAN DIEGO — C. Noel Bairey Merz, MD, FACC, director of the Barbra Streisand Women’s Heart Center in the Cedars-Sinai Heart Institute, reviews the new…
VIDEO: New detection technology 'changes landscape' for radiation safety Meeting News CoverageVideo

VIDEO: New detection technology 'changes landscape' for radiation safety

May 28, 2015
BOSTON — In this video, Scott J. Pollak, MD, FACC, of Central Florida Cardiology Group, Orlando, outlines the benefits of new technology that can directly measure…
More News Headlines »
CME
Platelet Function and Genetic Testing Current Status and Use

Platelet Function and Genetic Testing: Current Status and Use

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
Meeting News Coverage Video
VIDEO: New detection technology 'changes landscape' for radiation safety

VIDEO: New detection technology 'changes landscape' for radiation safety

May 28, 2015
BOSTON — In this video, Scott J. Pollak, MD, FACC, of Central Florida Cardiology Group, Orlando, outlines the…
More »
CME
Examining Diverse Patient Populations and Their Response to Therapy

Examining Diverse Patient Populations and Their Response to Therapy

This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC

Acute coronary syndrome (ACS) can result in substantial morbidity or death. To reduce the risk of cardiovascular death…
More »
morganatic-roan
morganatic-roan